Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Medieval Remedy Found to be Highly Effective Against MRSA

March 31, 2015 | by Stephanie Guzowski, Editor | News | Comments

British researchers recently found that a thousand-year-old Anglo-Saxon treatment for eye infections works as an antibiotic against MRSA. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Blood-Based Biomarkers Could Enable Accurate TB Tests for Diagnosis

March 31, 2015 11:48 am | by Emory University | News | Comments

Researchers have identified blood-based biomarkers in patients with active tuberculosis (ATB) that could lead to new blood-based diagnostics and tools for monitoring treatment response and cure. Read more...

TOPICS:

Quintiles, Quest to Join to Provide Global Clinical Trials Lab Services

March 31, 2015 11:38 am | News | Comments

Quintiles and Quest Diagnostics announced a definitive agreement to form a global clinical trials laboratory services business. Read more...

TOPICS:

Publication Bias, 'Spin,' Raise Questions About Anxiety Drugs

March 31, 2015 11:32 am | by Oregon State University | News | Comments

A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders. Read more...

TOPICS:
Advertisement

Arizona Governor Signs Abortion Drug Notification Mandate

March 31, 2015 11:22 am | by Bob Christie and Ryan Van Velzer, Associate Press | News | Comments

Gov. Doug Ducey signed a bill Monday that requires abortion providers in Arizona to tell women they can reverse the effects of a drug-induced abortion and also bars women from buying any health care plan through the federal marketplace that includes abortion coverage. Read more...

TOPICS:

Merck Serono, Intrexon Agree to Develop, Commercialize CAR-T Therapy

March 31, 2015 10:21 am | News | Comments

Merck Serono, the biopharmaceutical business of Merck, and Intrexon Corporation announced an exclusive strategic collaboration and license agreement to develop and commercialize Chimeric Antigen Receptor T-cell (CAR-T) cancer therapies. Read more...

TOPICS:

BioDelivery Sciences’ Pain Treatment Fails Study

March 30, 2015 3:46 pm | by Stephanie Guzowski, Editor | News | Comments

BioDelivery Sciences International Inc. said on Monday its pain drug for diabetic neuropathy failed to meet the primary goal in a Phase 3 clinical trial. Shares fell nearly 30 percent. Read more...

TOPICS:

Novartis, Aduro: Up-to-$750M Cancer Immunotherapy Collaboration

March 30, 2015 12:52 pm | by Stephanie Guzowski, Editor | News | Comments

Novartis is planning to boost its cancer immunotherapy pipeline with a collaboration with California-based Aduro Biotech worth up to $750 million. Read more...

TOPICS:

The Genomic Portrait of a Nation

March 29, 2015 4:01 pm | News | Comments

The studies present the most detailed portrait of a population yet assembled using the latest technology for reading DNA. Read more...

TOPICS:
Advertisement

Novo to Launch Novoeight in the U.S. for People With Hemophilia A

March 29, 2015 3:38 pm | News | Comments

The US Food and Drug Administration (FDA) approved Novoeight for use in adults and children with hemophilia A for the control and prevention of bleeding, perioperative management, and routine prophylaxis. Read more...

TOPICS:

Integrative Approaches Key to Understanding Cancer and Developing Therapies

March 29, 2015 3:16 pm | by Moffitt Cancer Center | News | Comments

Researchers are using integrative approaches to study cancer by combining mathematical and computational modeling with experimental and clinical data. Read more...

TOPICS:

Colleges Getting Out of Health Insurance Business

March 29, 2015 3:05 pm | by Donna Gordon Blankinship, Associated Prss | News | Comments

The federal health care overhaul is leading some colleges and universities to get out of the health insurance business. Read more...

TOPICS:

Meet the Head of Bayer's U.S. Science Hub: Chris Haskell

March 27, 2015 3:42 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Haskell's role is to establish partnerships with life science startups working on intriguing projects. Read more...

TOPICS:

Cells Rebound after Treatment for Most Children with HIV, Low Immune Cell Count

March 27, 2015 2:13 pm | by Enrique Rivero, UCLA | News | Comments

Most children with HIV who have low levels of a key immune cell eventually recover levels of this cell after they begin treatment. Read more...

MRI based on Sugar Molecule Can Tell Cancerous from Noncancerous Cells

March 27, 2015 2:06 pm | by Johns Hopkins University | News | Comments

Preliminary study in lab-grown cells raises possibility of cancer diagnosis without biopsies. Read more...

TOPICS:

Nanoparticle Therapy Promotes Wound Healing

March 27, 2015 2:00 pm | by Yeshiva University | News | Comments

An experimental therapy can cut in half the time it takes to heal wounds compared to no treatment at all. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading